University of Pittsburgh

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).

1,238 total trials 160 currently recruiting 917 completed early-phase tilt top decile by trial count

University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.

University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,238 total, page 21 of 25

COMPLETED NA

Effect of Glucosamine on Joint Structure and Quality of Life (JOG)

NCT00377286
COMPLETED Early Phase 1

7 Day Continuous Parathyroid Hormone IV Infusion

NCT00377312
COMPLETED

Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients

NCT00304330
TERMINATED NA

Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise

NCT00382473
COMPLETED

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

NCT00363220
COMPLETED Phase 3

Identification and Therapy of Postpartum Depression

NCT00282776
COMPLETED

Middle Ear Pressure Disregulation After Tympanostomy Tube Insertion

NCT00393900
COMPLETED

A Retrospective Review of Infections Usually Observed in Transplant Recipients

NCT00298077
COMPLETED

rATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation

NCT01207141
COMPLETED

Changing Patterns of Candida Infections in Urban Medical Centers

NCT00366223
COMPLETED

Prospective Evaluations of Infectious Complication in Lung Transplant Recipients

NCT00177918
COMPLETED

Eustachian Tube Growth and Development

NCT00422929
COMPLETED

Menstrual Effects On Mood Symptoms in Bipolar Disorder

NCT00472615
COMPLETED

Antimanic Drug Use in Pregnancy

NCT00585702
COMPLETED NA

Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?

NCT00360282
COMPLETED

Middle Ear Pressure Disregulation in Cleft Palate Patients

NCT00423072
COMPLETED Phase 1

Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight

NCT00226226
COMPLETED NA

Re-energize With Nutrition, Exercise and Weight Loss

NCT00712127
COMPLETED Phase 2

Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy

NCT00336856
COMPLETED Phase 4

Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D)

NCT01233648
COMPLETED Phase 2

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

NCT00492206
COMPLETED

Intravenous Voriconazole in Patients With Renal Compromise

NCT00332410
COMPLETED

Organ Transplant Infection Prevention and Detection Project

NCT00177801
COMPLETED Phase 2

Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

NCT00029614
COMPLETED Phase 1

Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study

NCT00360581
COMPLETED Phase 4

Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes

NCT00315952
COMPLETED NA

Patient Preference Survey for Radiation Oncologists

NCT00595218
COMPLETED

Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies

NCT00312624
COMPLETED

Infectious Outcomes Following Pancreas Transplantation

NCT00332111
COMPLETED Phase 2

Study of Pharmacology of 17-OHPC in Pregnancy

NCT00409825
COMPLETED

Long-term Effects of Bariatric Surgery

NCT00465829
COMPLETED Phase 2

Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)

NCT00307294
COMPLETED Phase 2

Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation

NCT00330993
COMPLETED Phase 2

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

NCT00106184
COMPLETED

NCCLS Interpretive Criteria for Salmonella

NCT00177658
COMPLETED Phase 1

Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer

NCT00291707
COMPLETED

Antibiotic Resistant Community-Acquired E. Coli

NCT00298103
COMPLETED

Ultrasound Scanning of Vascular Access Sites

NCT00330837
TERMINATED Phase 3

WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients

NCT00275314
TERMINATED

Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells

NCT00410267
COMPLETED Phase 3

Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study

NCT00177710
COMPLETED NA

Cognitive Assessment of Elderly Primary Care Patients

NCT01492335
COMPLETED Phase 2

Home Based Treatment for Drug Use in Early Adolescents

NCT00280228
COMPLETED

Developing and Assessing Competencies for Caregivers and Patients With Ventricular Assist Devices

NCT00178009
COMPLETED

Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria

NCT00275327
COMPLETED Phase 4

Bipolar Radiofrequency Ablation -Role in Prevention of Postoperative Atrial Fibrillation

NCT00765089
COMPLETED

Effect of Denileukin Diftitox on Immune System in CTCL Patients

NCT00254332
COMPLETED

Genomics and Postoperative Atrial Fibrillation

NCT00280163
COMPLETED

X-Chromosome Inactivation Status and Premature Ovarian Failure

NCT00295087
COMPLETED NA

Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway

NCT00248755
← Previous Page 21 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 81
Phase 2 79
Phase 3 28
Phase 4 56

Therapeutic Areas

Depression 17
Obesity 16
Sleep 10
Stroke 10
Cancer 10
Diabetes 7
Chronic Pain 7
Sleep Disturbance 6
Anxiety 6
Bipolar Disorder 5

What is open in the University of Pittsburgh pipeline

160 recruiting of 1,238 indexed (13% open); 917 completed (74%).

Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Pittsburgh: open-pipeline peers nationwide

Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20%22% Total trials Recruiting share University of PittsburghNorthwestern UniversityEmory UniversityUniversity of Colorado, DenverAstraZenecaIntermountain Health CareMcMaster UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Temple University
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,238 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Pittsburgh page

1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.

  • 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.